Stronger Sell Today SRNE ranks #4202 as SELL CANDIDATE. Weaker Sell
Today SRNE ranks #4202 as SELL CANDIDATE.

SRNE stock Sorrento Therapeutics

SRNE stock
Sorrento Therapeutics

18 January 2019
Change 1.32%
Chart period: 2018-10-19 - 2019-01-18
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Buy
Request Prediction
Predict

Sorrento Therapeutics Stock Analysis

Technical stock analysis for 18 January 2019

Sell candidate since 2019-01-08 Loss -12.55%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.68
ROA -19.64

Sorrento Therapeutics gained 1.32% in the last trading day, rising from $2.27 to $2.30 The price has fallen in 6 of the last 10 days and is down by -10.85% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.07 million more shares were traded than the day before. In total, 1.30 million shares bought and sold for approximately $2.99 million.

Close price at the end of the last trading day (Friday, 18th Jan 2019) of the SRNE stock was $2.30. This is 1.32% more than the trading day before Thursday, 17th Jan 2019.

During day the stock fluctuated 4.48% from a day low at $2.23 to a day high of $2.33.

30 day high of the SRNE stock price was $2.91 and low was $1.95.
90 day high was $4.56 and low was $1.95.
52 week high for the Sorrento Therapeutics - $10.65 and low - $1.95.

Trend

Sorrento Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.59% during the next 3 months and, with 90% probability hold a price between $1.08 and $2.07 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Tuesday January 15, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Sorrento Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.34 and $2.61. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Sorrento Therapeutics finds support from accumulated volume at $2.23.

Support: $2.23 Price: $2.30 Resistance: $2.47

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.10 between high and low, or 4.48%. For the last week, the stock has had a daily average volatility of 7.94%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Sorrento Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today SRNE ranks #4202 as SELL CANDIDATE. Weaker Sell
Today SRNE ranks #4202 as SELL CANDIDATE.